The study, published in Nature Biotechnology, highlights the role of Chemistry42 and its submodules in supporting drug candidate design and optimization. The research underscores the potential of ...
Insilico Medicine, a clinical-stage biotechnology company driven by generative artificial intelligence (AI), today announces the development of novel pan-KRAS inhibitors of new chemotypes through ...
Scientists in England have designed and synthesized the first inhibitors of an enzyme that is essential for the survival of the tuberculosis bacterium [Org. Biomol. Chem., 2, 2418 (2004)]. The ...
A decade ago, when Courtney Miller of Scripps Research in Florida found that blocking a specific protein can interrupt methamphetamine addiction in mice, it was difficult to imagine drugs targeting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results